Explore every episode of the podcast Decera Clinical Education Medical Specialties Podcast

Dive into the complete episode list for Decera Clinical Education Medical Specialties Podcast. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.

	Title	Pub. Date	Duration
	Key PBC Studies From AASLD 2025 Podcast	24 Dec 2025	00:14:58
Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice. Topics covered include: Treatment Goals Long-term Data With PPAR Agonists Investigational Therapies for Pruritus Presenter: Nancy Reau, MD Professor of Medicine Richard B. Capps Chair of Hepatology Chief, Section of Hepatology Associate Director, Solid Organ Transplantation Rush University Medical Center Chicago, Illinois To download the accompanying slides, visit the program page for this episode: https://bit.ly/4b2d6YD Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Bringing Obesity Advances to Primary Care: 2025 in Review and a Look Ahead	15 Dec 2025	00:25:41
Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including: The Lancet Commission’s new obesity definitions and diagnostic criteria Key data on incretin-based antiobesity medications like semaglutide and tirzepatide Best practices for patient discussions Strategies for incorporating new evidence in your primary care practice Presenters Jay H. Shubrook, DO, FACOFP, FAAFP Professor and Diabetologist Department of Clinical Sciences and Community Health Touro University California College of Osteopathic Medicine Vallejo, California Christopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA Bariatric Services Medical Director, Ascension Wisconsin Obesity Medicine Director, Ascension Columbia St Mary’s Bariatric Center Trustee, Obesity Medicine Association Adjunct Assistant Professor of Pediatrics Medical College of Wisconsin Milwaukee, Wisconsin Link to full program: https://bit.ly/4rG7QQp Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Setting Our Sights on Symptom Management: Raising the Bar in PBC Management Podcast	11 Dec 2025	00:38:04
Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help. Topics covered include: Mechanisms of pruritus and fatigue in PBC Nonpharmacologic treatment options An overview of clinical trial data supporting second-line agents for symptom management: Bezafibrate Elafibranor Seladelpar Investigational agents: Volixibat Linerixibat Setanaxib This episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Second-line Agents for Achieving Treatment Goals: Raising the Bar in PBC Management Podcast	11 Dec 2025	00:16:53
New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals. Topics covered include: Available agents for second-line treatment of PBC An overview of clinical trial data supporting second-line agents: Obeticholic acid (OCA) Bezafibrate Elafibranor Seladelpar This episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Defining Our Treatment Goals: Raising the Bar in PBC Management Podcast	10 Dec 2025	00:17:49
Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include: How and when to assess treatment response Risk factors in PBC Biochemical treatment response and fibrosis stage as predictors of transplant-free survival Dynamics of liver stiffness measurements and clinical outcomes in PBC The importance of bilirubin and alkaline phosphatase normalization This episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os Presenters: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Aparna Goel, MD Clinical Associate Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Aliya F. Gulamhusein, MD, MPH, FRCPC Professorship in PSC Research Clinician Investigator, Toronto General Hospital Assistant Professor, University of Toronto Division of Gastroenterology and Hepatology University Health Network Toronto, Canada Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Gaps and Unmet Needs in PBC Care	21 Nov 2025	00:26:51
Join expert faculty, Dr Alan Bonder and Dr Stuart Gordon, to learn more about key gaps in PBC management and how these shortfalls can be addressed through identification of appropriate biochemical goals, proper assessment and management of PBC symptoms, and current second-line therapies. Presenters: Alan Bonder, MD, AGAF Associate Professor of Medicine Medical Director of Liver Transplant Beth Israel Deaconess Medical Center Department of Gastroenterology Harvard Medical School Boston, Massachusetts Stuart C. Gordon, MD, FAASLD Professor of Medicine Wayne State University School of Medicine Professor of Medicine Michigan State University College of Medicine Henry Ford Health Detroit, Michigan Link to full program: https://bit.ly/3M29pI1 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Patient Perspectives on New Developments in PBC: Individualizing Patient Care Podcast	20 Oct 2025	00:12:48
Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include: The Canadian PBC Society Survey: Comorbidities and Treatment Goals Defining and Achieving Goal-Driven Care for PBC Recent Advances in PBC Management Newer Agents for Second-line Treatment of PBC Presenters: Maria G. Morais, RN PBC Transplant Patient VP Patient Advocacy Canadian PBC Society Toronto, Canada Link to full program: https://bit.ly/44ySoL3 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Keeping Up With New Developments in PBC	17 Oct 2025	00:48:04
Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice. Topics covered include: Methods of Assessing PBC Disease Progression Newer Agents for Second-line Treatment of PBC Prioritizing Symptom Management and Quality of Life With PBC Treatment Presenters: Christopher L. Bowlus, MD Lena Valenta Professor and Chief Division of Gastroenterology and Hepatology School of Medicine University of California Davis Sacramento, California Sonal Kumar, MD, MPH Assistant Professor of Medicine Division of Gastroenterology and Hepatology Weill Cornell Medical College New York, New York Link to full program: https://bit.ly/43nHx6U Get access to all of our new podcasts by subscribing to the CCO Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Conversations in Chronic Cough: A Pulmonologist’s Perspective	09 Sep 2025	00:16:43
Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies. Presenter Peter Dicpinigaitis, MD Professor of Medicine Albert Einstein College of Medicine Division of Critical Care Medicine Montefiore Medical Center Director, Montefiore Cough Center Bronx, New York Link to full program: https://bit.ly/4kweynG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Conversations in Chronic Cough: An Otolaryngologist’s Perspective	11 Jul 2025	00:18:07
Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case. Presenter Michael S. Benninger, MD Professor of Otolaryngology-Head and Neck Surgery Lerner College of Medicine The Cleveland Clinic President, International Association of Phonosurgery Cleveland, Ohio Link to full program: https://bit.ly/4kweynG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Quality Improvement in Obesity Care: How to Integrate Comprehensive Diabetes Management	10 Jul 2025	00:19:17
Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss how to integrate comprehensive diabetes management to improve the quality of their obesity care delivery, including: Documenting obesity as a diagnosis for patients with diabetes when appropriate Streamlining processes to ensure patients return for follow-up Dedicating a care manager to initiate patient outreach Implementing pharmacotherapy strategies to help patients control their A1C and achieve weight loss simultaneously. Presenters Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Colten Bracken, MD, FAAFP Board of Directors for RHAU & UAFP Owner/Medical Director Main Street Family Medicine, PLLC Enterprise, Utah Link to full program: https://bit.ly/3IBFZi5 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Key PBC Studies From EASL and DDW 2025	07 Jul 2025	00:18:54
In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include: Steatotic liver disease and PBC Vibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBC PPAR agonists and IBATs for PBC treatment Presenter: Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH Associate Professor NIHR Birmingham BRC University of Birmingham Consultant Hepatologist, Liver Unit University Hospitals Birmingham Birmingham, United Kingdom Link to full program: https://bit.ly/44ySoL3 Follow along with the slides: https://bit.ly/3IvwQrj Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify . Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease	25 Jun 2025	00:09:53
In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including: Patient candidacy considerations Treatment advancement strategies that go beyond topical therapies The importance of patient-centered care that address patients’ fears and needs A detailed patient case to highlight take home points Presenter Daniel C. Butler, MD Assistant Dean Student Affairs University of Arizona College of Medicine – Tucson Tucson, Arizona Shawn G. Kwatra, MD Dr. Joseph W. Burnett Endowed Professor and Chair Department of Dermatology University of Maryland School of Medicine Baltimore, Maryland Program page: https://bit.ly/4kTP04D Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Evidence-Based Care in Atopic Dermatitis: IL-13 Inhibitors to Treat Moderate to Severe Disease	25 Jun 2025	00:15:48
In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including: The available biologic therapies that specifically target IL-13 Where these agents fall in the 2024 American Academy of Dermatology treatment algorithm How these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitors A detailed patient case to highlight take home points Presenter Andrew F. Alexis, MD, MPH Professor of Clinical Dermatology Weill Cornell Medical College New York, New York Daniel C. Butler, MD Assistant Dean Student Affairs University of Arizona College of Medicine – Tucson Tucson, Arizona Shawn G. Kwatra, MD Dr. Joseph W. Burnett Endowed Professor and Chair Department of Dermatology University of Maryland School of Medicine Baltimore, Maryland Program page: https://bit.ly/4kTP04D Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Quality Improvement in Obesity Care: How to Manage Prior Authorizations for Antiobesity Medications	24 Jun 2025	00:27:06
Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including: The information to collect during patient visits The available resources to help you submit prior authorizations The supporting documents that are often necessary to accompany prior authorizations How to address denials and appeals When to access manufacturer-based or foundation-based financial assistance Presenters Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Manish Shah, MD Clinical Associate Faculty MS1 Preceptor University of Florida College of Medicine Gainesville, Florida Martha Grugel, MA Medical Assistant Wesley Chapel, Florida Link to full program: https://bit.ly/45P0v8z Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease	24 Jun 2025	00:11:40
In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including: Contributors to epidermal barrier dysfunction (eg, environmental triggers) IL-13 as a key cytokine in AD pathogenesis Targeted AD therapies that inhibit IL-13 A detailed patient case to highlight take-home points Presenter Andrew F. Alexis, MD, MPH Professor of Clinical Dermatology Weill Cornell Medical College New York, New York Daniel C. Butler, MD Assistant Dean Student Affairs University of Arizona College of Medicine – Tucson Tucson, Arizona Program page: https://bit.ly/4kTP04D Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Innovations in NCFBE: Latest Advances and Personalization of Treatment	20 Jun 2025	00:15:39
In this podcast, Anne E. O’Donnell, MD, discusses the latest advances and treatment strategies for patients with non–cystic fibrosis bronchiectasis (NCFBE), including: Airway clearance as a foundation of NCFBE management Strategies to address inflammation and exacerbations Emerging therapies in clinical development How to individualize treatment to NCFBE phenotypes and endotypes Presenter Anne E. O’Donnell, MD Professor of Medicine The Nehemiah and Naomi Cohen Chair in Pulmonology Disease Research Chief, Division of Pulmonary, Critical Care and Sleep Medicine Georgetown University Medical Center Washington, DC Program page: https://bit.ly/4mZbYsm Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Heart Failure and MRAs: Diving Deep Into the Pivotal FINEARTS-HF Trial	18 Jun 2025	00:22:14
In this podcast, Ty J. Gluckman, MD, MHA, discusses the pivotal phase III FINEARTS-HF trial and how the treatment landscape is evolving for patients with heart failure (HF) with mildly reduced or preserved ejection fraction, including: The emerging role of mineralocorticoid receptor antagonists in HF care Finerenone’s efficacy in reducing composite cardiovascular death and worsening HF events Why safety must be monitored, especially considering hyperkalemia risk Where HF guideline recommendations lack compared with the current evidence Presenter Ty J. Gluckman, MD, MHA Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS) Providence Heart Institute Providence Health System Portland, Oregon Program page: https://bit.ly/448XcH0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Innovations in NCFBE: Understanding the Patient Burden and Best Practices in Diagnostics	18 Jun 2025	00:23:32
In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including: The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection) Cough as the most significant symptom and burden Imaging bronchiectasis with classic and inflammatory findings Differentiating the causes of NCFBE to inform patient care Presenters Brett M. Elicker, MD Professor of Clinical Radiology Chief, Cardiothoracic Imaging Division Department of Radiology & Biomedical Imaging University of California, San Francisco San Francisco, California David E. Griffith, MD, ATSF, FACCP, FRSM Professor of Medicine Division of Mycobacterial and Respiratory Diseases Department of Medicine National Jewish Health Denver, Colorado Program page: https://bit.ly/4mZbYsm Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Quality Improvement in Obesity Care: How to Develop Patient-Centered and Tailored Treatment Plans	13 Jun 2025	00:27:07
Listen in as Joseph Kim, MD, MPH, MBA, interviews Natalie, Orbach, PA-C, to learn about how she implemented patient-centered and individualized treatment plans to improve obesity care at her practice, including Discussing weight and how nutrition, physical activity, mental health, and pharmacotherapy strategies can help Meeting patients where they are at and offering slow, incremental changes that support long-term outcomes Referring patients to community resources and other professionals as need Sharing lessons learned for those interested in implementing similar strategies in their practice Presenter Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Natalie Orbach, PA-C Physician Assistant Feirtag & Ramos, PA Lutherville, Maryland Link to full program: https://bit.ly/45P0v8z Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Conversations in Chronic Cough: An Allergist’s Perspective	28 May 2025	00:16:36
Listen as Michael S. Blaiss, MD provides case-based perspectives on chronic cough recognition, burden, management, and pathophysiology and describes the evolving treatment landscape for refractory chronic cough. Presenter Michael S. Blaiss, MD Clinical Professor of Pediatrics Division of Allergy-Immunology Medical College of Georgia at Augusta University Augusta, Georgia Link to full program: https://bit.ly/4kweynG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Expert Guidance in Alpha-1 Antitrypsin Deficiency: Why Early Detection and Multidisciplinary Management Are Key	09 May 2025	00:30:18
Listen in as Paula Henao, MD; Rohit Loomba, MD, MHSc; Cheryl Pirozzi, MD, MS; and Corinne Young, NP, FCCP, discuss their screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including: Why early detection is key for improving patient outcomes How to monitor through use of noninvasive imaging and biopsy per guideline recommendations How to coordinate patient care to provide much-needed multidisciplinary care What therapies in the pipeline could transform the treatment landscape for this genetic disease Presenters Paula Henao, MD Assistant Professor of Medicine Division of Pulmonary, Allergy and Critical Care Medicine Penn State Hershey Medical Center Hershey, Pennsylvania Rohit Loomba, MD, MHSc Professor of Medicine Chief, Division of Gastroenterology and Hepatology Director, MASLD Research Center University of California, San Diego San Diego, California Cheryl Pirozzi, MD, MS Associate Professor of Internal Medicine Division of Pulmonary and Critical Care Medicine University of Utah Salt Lake City, Utah Corinne Young, NP, FCCP President/Founder Association of Pulmonary Advanced Practice Providers Colorado Springs, Colorado Link to full program: https://bit.ly/4dgCRnq Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Quality Improvement in Obesity Care: How to Implement Virtual Support Groups	07 May 2025	00:27:27
Listen in as Joseph Kim, MD, MPH, MBA, interviews Sejal Desai, MD, DABOM, to learn about how she implemented virtual support groups to improve obesity care at her practice, including: Dedicating 5 support groups with chat features to obesity-specific topics (eg, sleep, nonscale wins) Moderating these chats to ensure no misinformation is shared and a positive, safe space is maintained Expanding to include other virtual options that allow patients to engage more in their care Utilizing free and subscription-based services to aid in marketing efforts Sharing lessons learned for those interested in implementing similar virtual options for their patients Presenters Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Sejal Desai, MD, DABOM Board-Certified Obesity Medicine Physician Owner & Medical Director Tula Medical Weight Loss & Wellness Katy, Texas Link to full program: https://clinicaloptions.com/content/qi-resource-hub Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Quality Improvement in Obesity Care: How to Implement Documentation Shortcuts	11 Apr 2025	00:24:05
Listen in as Joseph Kim, MD, MPH, MBA, interviews Sophia Kwon, MD, to learn about how she implemented a documentation shortcut at her institution to improve obesity care, including: Creating an obesity checklist within the electronic health record Training staff to correctly use this checklist and broach obesity topics with patients Garnering feedback to ensure this checklist did not add to note fatigue or burnout among staff Sharing lessons learned for others interested in implementing a similar documentation shortcut Presenter Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Sophia Kwon, MD Internal Medicine Attending Riverside University Health System Attending Loma Linda University Health Associate Faculty Loma Linda, California Link to full program: https://clinicaloptions.com/content/qi-resource-hub Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Partnering With Patients for PBC Care: Actionable Strategies for HCPs	01 Apr 2025	00:13:45
In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss challenges related to the diagnosis and management of primary biliary cholangitis (PBC) to provide actionable strategies for healthcare professionals to incorporate into patient care, including: Disease concerns and frequently asked questions from a patient perspective Managing symptoms Treatment options and supportive care Importance of awareness and education Presenters: Gideon Hirschfield, MA, MB BChir, FRCP, PhD Lily and Terry Horner Chair in Autoimmune Liver Disease Research Professor, Division of Gastroenterology and Hepatology University of Toronto Director, The Autoimmune and Rare Liver Disease Programme Director, Francis Family Liver Clinic Toronto General Hospital, University Health Network Ontario, Canada Jess N. Schnur, BSN-RN National PBC Patient Advocate American Liver Foundation Donation Support Services Coordinator Lifeline of Ohio Columbus, Ohio To learn more, see the program Hear Me: Patient Perspectives on PBC Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Debating the Role of ALP Normalization in PBC: Curbside Consults Podcast	24 Mar 2025	00:21:00
In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau, use an illustrative patient case to explore the roles of ALP and other biochemical markers in PBC management, and explain what to expect from treatment. Topics covered include: How baseline ALP can affect ALP normalization after second-line treatment with elafibranor and seladelpar Potential outcomes if ALP normalization cannot be achieved The importance of managing fatigue, pruritus, and sleep disturbances independently of the biochemical response Presenters: Stuart C. Gordon, MD Professor of Medicine Wayne State University School of Medicine Director, Division of Hepatology Henry Ford Health Detroit, Michigan Nancy Reau, MD Professor of Medicine Richard B. Capps Chair of Hepatology Chief, Section of Hepatology Associate Director, Solid Organ Transplantation Rush University Medical Center Chicago, Illinois To learn more about PBC management, check out our program, Curbside Consults: Expert Insights on Challenges in PBC Management. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Managing PBC Therapy for Patients With Cirrhosis: Curbside Consults Podcast	18 Mar 2025	00:16:08
In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau discuss an illustrative patient case to demonstrate how they individualize primary biliary cholangitis (PBC) therapy for patients with cirrhosis. Topics covered include: AASLD guideline recommendations for second-line therapy for PBC Considerations when using newer agents for second-line treatment of PBC in patients with cirrhosis: elafibranor and seladelpar Presenters: Stuart C. Gordon, MD Professor of Medicine Wayne State University School of Medicine Director, Division of Hepatology Henry Ford Health Detroit, Michigan Nancy Reau, MD Professor of Medicine Richard B. Capps Chair of Hepatology Chief, Section of Hepatology Associate Director, Solid Organ Transplantation Rush University Medical Center Chicago, Illinois To learn more about PBC management, check out our program, Curbside Consults: Expert Insights on Challenges in PBC Management. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Evaluating and Managing PBC Symptoms: Curbside Consults Podcast	24 Feb 2025	00:18:43
In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss how they assess the symptoms of primary biliary cholangitis (PBC) and explore how new therapeutic agents may help alleviate symptom burden. Topics include: Strategies and tools for assessing pruritus Nonpharmacologic and pharmacologic management of pruritus Second-line agents and their impact on pruritus Investigational treatments for pruritus Presenters: Alan Bonder, MD, AGAF Associate Professor of Medicine Medical Director of Liver Transplant Department of Gastroenterology Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts Aparna Goel, MD Associate Clinical Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Content based on an online CME program supported by independent educational grants from Gilead Sciences, Inc., and Ipsen Biopharmaceuticals, Inc. To learn more about PBC management, check out our program, Curbside Consults: Expert Insights on Challenges in PBC Management. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Defining Nonresponse to PBC Treatment: Curbside Consults Podcast	24 Feb 2025	00:18:55
How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including: How and when to measure treatment response Evidence-based goals of therapy Considerations for second-line treatment New agents for second-line treatment: PPAR agonists Presenters: Alan Bonder, MD, AGAF Associate Professor of Medicine Medical Director of Liver Transplant Department of Gastroenterology Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts Aparna Goel, MD Associate Clinical Professor of Medicine Division of Gastroenterology and Hepatology Stanford University Palo Alto, California Content based on an online CME program supported by independent educational grants from Gilead Sciences, Inc., and Ipsen Biopharmaceuticals, Inc. To learn more about PBC management, check out our program, Curbside Consults: Expert Insights on Challenges in PBC Management. Supported by educational grants from Gilead Sciences, Inc. and Ipsen Biopharmaceuticals, Inc Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	PBC Perspectives: A Patient and HCP in Conversation	13 Feb 2025	00:27:29
In this podcast, Sonal Kumar, MD, MPH, meets with patient advocate Maria Morais to discuss actionable steps that healthcare providers can incorporate into the care of people with primary biliary cholangitis (PBC). Listen as they discuss: The chronic nature of PBC Going beyond biochemical markers to assess and address symptoms such as fatigue and pruritus The importance of referral to patient support groups Presenters: Sonal Kumar, MD, MPH Assistant Professor of Medicine Director, General Gastroenterology and Hepatology Weill Cornell Medical College New York, New York Maria G. Morais, RN VP Patient Advocacy Canadian PBC Society Toronto, Canada To learn more, see the program Hear Me: Patient Perspectives on PBC Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Expert Guidance on Managing Axial Spondyloarthritis and Psoriatic Arthritis to Improve Patient Outcomes and Quality of Life	29 Jan 2025	00:27:38
Listen in as rheumatology experts Alexis Ogdie, MD, MSCE, and Julia Swafford, PA-C, DFAAPA, discuss emerging therapies and strategies in managing patients with axial spondyloarthritis or psoriatic arthritis, including: The current treatment landscape (eg, small molecules, biologics) Risk factors to consider when prescribing JAK inhibitors Key considerations regarding comorbidities, especially in addressing depression, anxiety, or social ideation Nonpharmacologic options to improve treatment outcomes Shared decision-making strategies to enhance patients’ investment in their care Presenter: Alexis Ogdie, MD, MSCE Director, Penn Psoriatic Arthritis and Spondylarthritis Program Director, Penn Center for Clinical Epidemiology and Biostatistics University of Pennsylvania Philadelphia, Pennsylvania Julia Swafford, PA-C, DFAAPA President of SPAR Bronson Battle Creek Rheumatology Specialists Battle Creek, Michigan Link to full program: https://bit.ly/4gkTzSv Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Key PBC Studies From AASLD 2024	07 Jan 2025	00:20:16
In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including: ELATIVE, a phase III trial of elafibranor for PBC RESPONSE, a phase III trial of seladelpar for PBC ASSURE, another phase III trial of seladelpar for PBC Presenter: Sonal Kumar, MD, MPH Director, Clinical Gastroenterology and Hepatology Assistant Professor of Medicine Weill Cornell Medical College New York, New York Link to full program: https://bit.ly/41tvSDu Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Emerging Therapies for Pruritus in PBC	18 Dec 2024	00:23:34
Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients’ quality of life. Listen as they discuss: Gaps in current management Patient perspectives: why we should not dismiss itching as an underlying psychologic problem PPAR agonists and how they affect pruritus BEZURSO and FITCH ELATIVE ENHANCE and RESPONSE IBATs (inhibitors of bile acid transport) GLIMMER Common questions Presenters: Marlyn J. Mayo, MD Professor of Internal Medicine Division of Digestive & Liver Diseases UT Southwestern Medical Center Dallas, Texas Stuart C. Gordon, MD Professor of Medicine Wayne State University School of Medicine Director, Division of Hepatology Henry Ford Health Detroit, Michigan Pam Rivard, RN Person living with PBC Link to full program: https://bit.ly/3Dnfb2E Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Clinical Management of Pruritus in PBC	18 Dec 2024	00:21:18
Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including: Pruritus assessment tools Optimal use of tools, including frequency of assessment Current management of pruritus Nonpharmacologic interventions Pharmacologic agents Strategies to optimize assessment and management of pruritus Collaborative care Development of a treatment plan Ongoing assessment and adjustment of therapy Resources and support for patients Presenters: Marlyn J. Mayo, MD Professor of Internal Medicine Division of Digestive & Liver Diseases UT Southwestern Medical Center Dallas, Texas Stuart C. Gordon, MD Professor of Medicine Wayne State University School of Medicine Director, Division of Hepatology Henry Ford Health Detroit, Michigan Pam Rivard, RN Person living with PBC Link to full program: https://bit.ly/3Dnfb2E Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Living With Pruritus in PBC: A Patient Perspective	18 Dec 2024	00:12:19
In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective. Presenters: Marlyn J. Mayo, MD Professor of Internal Medicine Division of Digestive & Liver Diseases UT Southwestern Medical Center Dallas, Texas Stuart C. Gordon, MD Professor of Medicine Wayne State University School of Medicine Director, Division of Hepatology Henry Ford Health Detroit, Michigan Pam Rivard, RN Person living with PBC Link to full program: https://bit.ly/4gDGDaB Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Recent Advances in PBC Management	12 Dec 2024	00:08:46
In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including: Treatment goals Use of PPAR agonists for the treatment of PBC Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO) Presenter: Christopher L. Bowlus, MD Lena Valente Professor and Chief Division of Gastroenterology and Hepatology University of California Davis School of Medicine Sacramento, California Link to full program: https://bit.ly/41tvSDu Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Navigating Sjogren's Syndrome: Guiding Patients in Their Care Journey	04 Nov 2024	00:24:11
Listen as Elizabeth Kircher, DNP, and R. Hal Scofield, MD, discuss best practice approaches for the treatment of Sjögren’s syndrome and what’s on the horizon for future therapeutic options. Topics include: Challenges in Sjogren’s Syndrome Diagnosis and Patient Understanding: Difficulties in explaining Sjogren’s syndrome diagnosis to patients unfamiliar with it and challenges in addressing the disease’s varied symptoms Patient Education and Communication: Strategies to prevent overwhelming patients during early visits and effective ways to address misconceptions Diagnostic Challenges and Misunderstandings: Differences between clinical and research criteria for diagnosis and the importance of understanding each Use of Ultrasound and Biopsy in Diagnosis: Benefits and limitations of ultrasound and biopsies in diagnosing Sjogren’s syndrome Multidisciplinary Care Barriers: Challenges in coordinating care among specialists such as ophthalmologists, dentists, and rheumatologists Symptomatic vs Disease-Modifying Treatments: Strategies for managing symptoms vs addressing the underlying disease with medications Long-term Medication and Risks: Considerations when prescribing long-term medications and immunosuppressive therapies Research and Emerging Therapies: Developments in Sjogren’s syndrome research, including promising medications in clinical trials Guideline Development and Patient Reassurance: The role of professional guidelines in shaping care and providing patients with reassurance Polypharmacy and Medication Reconciliation: The importance of pharmacist involvement in managing complex medication regimens for older patients Faculty: Elizabeth Kircher, DNP R. Hal Scofield, MD Member/Professor, Arthritis & Clinical Immunology Oklahoma Medical Research Foundation Professor, Department of Medicine, College of Medicine University of Oklahoma Health Sciences Center Associate Chief of Staff for Research Oklahoma City US Department of Veterans Affairs Medical Center Oklahoma City, Oklahoma Link to full program: https://bit.ly/3YKpsOE Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Paradigm Shifting Updates in IgAN: Expert Faculty Discussions of Recent Breakthroughs	09 Sep 2024	00:18:20
In this CCO Nephrology podcast episode, hear from nephrologists Pietro Canetta, MD, MS, and Andy Bomback, MD, PhD, experts in clinical management and research on glomerular diseases as they discuss key updates in managing IgAN. Faculty highlight the importance of a comprehensive supportive care regimen to protect patients’ kidneys and prevent progression of disease. In addition, they review the merits and place in therapy of novel and emerging therapies. Topics include: Supportive care as the foundation of IgAN management Place in therapy for new and emerging agents Targeted-release formulation of budesonide Endothelin receptor antagonists (eg, sparsentan) Factor B inhibitors (eg, iptacopan) The role of clinical trial involvement Learn more about IgA nephropathy with educational activities and resources here: CME-certified text module with animated pathophysiology video and patient voice audio clip ClinicalThought commentaries Resources on IgAN from the American Kidney Fund Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Expert Discussions: Novel Agents Targeting Residual Inflammatory Risk in ASCVD and CKD	26 Aug 2024	00:15:28
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they discuss new and emerging therapies designed to target residual inflammatory risk associated with ASCVD and CKD.    Episode outline:   Colchicine: inhibition of NLRP3 inflammasome assembly/activation Canakinumab (anti–IL-1β monoclonal antibody) Ziltivekimab (anti–IL-6 monoclonal antibody) Other emerging targets/therapies To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:   CME-certified text module with animated pathophysiology video and faculty voice audio clips ClinicalThought commentaries Podcast episode 1, discussing residual risk associated with systemic inflammation and the role of cardiologists and nephrologists in mitigating risk in ASCVD and CKD Podcast episode 2, discussing novel therapeutic approaches to address residual inflammatory risks in patients with ASCVD and CKD Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD	26 Aug 2024	00:14:32
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD.    Episode outline:   The relationship among systemic inflammation, ASCVD, and CKD The role of cardiologists and nephrologists in screening and mitigating systemic inflammation To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:   CME-certified text module with animated pathophysiology video and faculty voice audio clips ClinicalThought commentaries Podcast episode 2, discussing novel therapeutic approaches to address residual inflammatory risks in patients with ASCVD and CKD Podcast episode 3, featuring faculty discussion of new and emerging therapies to target inflammatory risk in patients with ASCVD and CKD Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Expert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKD	26 Aug 2024	00:14:32
In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD.    Episode outline:   Moving beyond lipid lowering to address residual inflammatory risk Novel anti-inflammatory targets for ASCVD To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below:   CME-certified text module with animated pathophysiology video and faculty voice audio clips ClinicalThought commentaries Podcast episode 1, discussing residual risk associated with systemic inflammation and the role of cardiologists and nephrologists in mitigating risk in ASCVD and CKD Podcast episode 3, featuring faculty discussion of new and emerging therapies to target inflammatory risk in patients with ASCVD and CKD Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Navigating IgA Nephropathy: Insights From a Patient With Lived Experience	11 Jul 2024	00:21:53
In this CCO Nephrology podcast episode, hear from Kelly Chen, a nephrology nurse practitioner and patient living with IgA nephropathy, as she discusses her experiences with Dr Pietro Canetta, Associate Professor of Medicine at Columbia University and expert in glomerular diseases. Episode outline: Seeking and obtaining an IgAN diagnosis Patient self-advocacy Individualizing IgAN treatment plans Clinical trial involvement Burdens of IgAN: physical, emotional, social, and beyond To learn more about IgA nephropathy, find more educational activities and resources with the links below: CME-certified text module with animated pathophysiology video and patient voice audio clips ClinicalThought commentaries Resources on IgAN from the American Kidney Fund Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	How to Implement Earlier Hepatitis B Treatment	26 Mar 2024	00:21:27
In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness considerations Integration of patient perspectives in wider treatment Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center Johns Hopkins University School of Medicine Baltimore, Maryland Tatyana Kushner, MD, MSCE Associate Professor Division of Liver Diseases Icahn School of Medicine at Mount Sinai New York, New York Paul Y. Kwo, MD Professor of Medicine Director of Hepatology Stanford University School of Medicine Palo Alto, California Jacki Chen, PhD Patient Advocate Link to full program: https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/4a60GM4 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	The Art of Multidisciplinary Care for Patients With Metabolic Dysfunction–Associated Steatohepatitis	13 Mar 2024	00:29:38
In this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies. Presenters: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Division of Gastroenterology and Hepatology Weill Cornell Medicine New York, New York Mazen Noureddin, MD, MHSc Professor of Medicine Houston Methodist Hospital Director Houston Research Institute Houston, Texas Content based on an online CME program supported by independent educational grants from Novo Nordisk. To view the full program on “Clinical Pathways: Multidisciplinary Approach to Managing Metabolic Dysfunction‒Associated Steatohepatitis,” including 4 CME/CE-certified text modules with accompanying slidesets, 4 ClincalThought commentaries, and a downloadable infographic resource on the AGA MASLD MASH Clinical Care Pathway, visit clinicaloptions.com or click on the link below. Link to full program: https://bit.ly/3Tyu7At Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients	12 Feb 2024	00:32:19
In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes: Beneficial effects beyond glycemic control Adverse events and how to manage them Non- or partial responders and the importance of setting expectations with patients Weight rebound when discontinuing therapy Medication access issues related to cost and drug availability Presenters: Jennifer Green, MD Professor of Medicine Division of Endocrinology and Duke Clinical Research Institute Duke University School of Medicine Durham, North Carolina Carol Hatch Wysham, MD Clinical Professor of Medicine Clinical Endocrinologist MultiCare/Rockwood Clinic Spokane, Washington Link to online program: https://bit.ly/48b6XnW Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	How to Implement Earlier Hepatitis B and Hepatitis Delta Screening	22 Dec 2023	00:27:52
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screening for HBV Addressing patient-, provider-, and system-level barriers to universal HBV screening Best practices for implementation of HDV screening Presenters: Douglas Dieterich, MD Director, Institute for Liver Medicine Professor of Medicine Division of Liver Diseases Mount Sinai School of Medicine New York, New York Camilla S. Graham, MD, MPH Co-Director, Viral Hepatitis Clinic Division of Infectious Diseases Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts Robert Wong, MD, MS Clinical Associate Professor Division of Gastroenterology and Hepatology Stanford University School of Medicine Palo Alto, California Link to full program: https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/4atS42z Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Finding Your Friendtors: Mentors, Sponsors, and Allies	25 Sep 2023	00:28:53
In this podcast episode, Aline Charabaty, MD, AGAF, FACG, and Marla Dubinsky, MD, discuss how women in gastroenterology (GI) can find their “friendtors” and build a strong network of mentors, sponsors, and allies. Although there may be many barriers for women in the GI medicine specialty, these experienced leaders have useful tips to help emerging healthcare professionals avoid internalizing these challenges and strategically focus on accomplishing their goals. Presenters: Dr Aline Charabaty is an Assistant Professor of Medicine at Johns Hopkins School of Medicine, the Clinical Director of the IBD Centre at Johns Hopkins Sibley Memorial Hospital in Washington, DC, and the Co-Founder of Scrubs & Heels. Aline Charabaty, MD, AGAF, FACG: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb, Janssen, Lilly, Pfizer, Takeda. Dr Marla Dubinsky is a Professor of Pediatrics and Medicine at Mount Sinai in New York, Chief of Division of Pediatric GI and Nutrition at Mount Sinai Kravis Children's Hospital, and the Co-Director of the Susan and Leonard Feinstein IBD Clinical Centre. Dr Dubinsky is also the Director of the Marie and Barry Lipman IBD Preconception and Pregnancy Clinic. She is also an innovator and the Co-Founder of Trellus Health, providing personalized resilience coaching for people living with IBD. She received the Sherman Prize in 2022, which recognized her outstanding achievement in the field of IBD. In addition, she served as the Co-Chair for our inaugural Scrubs & Heels Leadership Summit in 2022. Marla Dubinsky, MD: consultant/advisor/speaker: AbbVie, Abivax, AstraZeneca, Bristol Myers Squibb, Janssen, Lilly, Merck, Pfizer, Prometheus Biosciences, Takeda. Episode outline: Overview of barriers faced by women in GI Impact of failing to adequately address these barriers Defining the roles of mentors, sponsors, and allies Important qualities of mentors, sponsors, and allies Role models vs peer mentors Other program activities: Full Program: Equipped and Empowered: Thriving as Women in GI Podcast 2: Embracing Your Value: Tools and Strategies for Optimizing Professional Growth and Development Podcast 3: Being Your Full Self: Pursuing Work–Life Balance ClinicalThought: Expert Commentary on Thriving as Women in GI After selecting the “Continue to Post Test” button: To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select 1 best answer for each question. When you have completed all the questions, press the "Continue" button at the bottom Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Embracing Your Value: Tools and Strategies for Optimizing Professional Growth and Development	25 Sep 2023	00:29:51
In this podcast episode, Anita Afzali, MD, MPH, MHCM, FACG, AGAF, and Aja McCutchen, MD, discuss how women in gastroenterology (GI) can embrace and enhance their value. These inspiring GI medicine experts propose a practical formula that involves ongoing, careful self-reflection and asking yourself how your strengths, core values, and interests can be aligned with professional endeavors. In addition, self-advocacy and self-allyship can serve as harmonious tools to drive action and positive change. Presenters: Dr Anita Afzali is a Professor of Clinical Medicine, Interim Division Director of the Division of Digestive Diseases, Executive Vice Chair of Medicine in the Department of Internal Medicine, and the Associate Chief Medical Officer of the UC Health system in Cincinnati, Ohio. She is also a Co-Founder of Scrubs & Heels. Anita Afzali, MD, MPH, MHCM, FACG, AGAF: consultant: AbbVie, Bristol Myers Squibb, Gilead Sciences, Janssen, Lilly, Pfizer, Takeda; provider of non-CME/CE services: AbbVie, Janssen, Pfizer, Takeda. Dr Aja McCutchen is a Partner and Physician Executive at Atlanta Gastroenterology Associates, a division of United Digestive in Atlanta, Georgia, and served as Co-Chair at the Scrubs & Heels 2023 Leadership Summit. Aja McCutchen, MD: consultant/advisor/speaker: Eli Lilly, Modify Health, Redhill Biopharm, Sanofi Regeneron, Takeda. Episode outline: Understanding and establishing your own market value; bringing that to your own organization Consequences of being ill-equipped to pursue professional growth and development Advocating for the value you bring to the profession Negotiation as a form of self-allyship Negotiation categories to help support career success and protect work–life balance Other program activities: Full Program: Equipped and Empowered: Thriving as Women in GI Podcast 1: Finding Your Friendtors: Mentors, Sponsors, and Allies Podcast 3: Being Your Full Self: Pursuing Work–Life Balance ClinicalThought: Expert Commentary on Thriving as Women in GI To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select 1 best answer for each question. When you have completed all the questions, press the "Continue" button at the bottom. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Being Your Full Self: Pursuing Work–Life Balance	25 Sep 2023	00:28:27
In this podcast episode, Aline Charabaty, MD, AGAF, FACG, and Christina Tennyson, MD, DipABLM, discuss how women in gastroenterology (GI) can fight burnout and establish a work–life balance that meets their needs. Tune in to learn how to say no, about the importance of saying yes to meaningful things that will advance your career and bring you joy, and get essential tips for well-rounded and ongoing self-care. Presenters: Dr Aline Charabaty is an Assistant Professor of Medicine at Johns Hopkins School of Medicine, the Clinical Director of the IBD Centre at Johns Hopkins Sibley Memorial Hospital in Washington, DC, and the Co-Founder of Scrubs & Heels. Aline Charabaty, MD, AGAF, FACG: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb, Janssen, Lilly, Pfizer, Takeda. Dr Christina Tennyson is a gastroenterologist with expertise and certification in nutrition, lifestyle medicine, and integrative medicine. She started her career in academia at Columbia University in New York before joining the Augusta Health Digestive Wellness program in the Virginia Shenandoah Valley, where she is engaged in a multidisciplinary program that includes culinary medicine classes and farm workshops for patients. Christina Tennyson, MD, DipABLM, has no relevant financial relationships to disclose. [Link to: https://scrubsandheels.com/] Episode outline: Variables that contribute to burnout Strategies to protect your time Vetting collaborative projects Requesting flexible schedules, part-time work, maternity leave Charting your own career path Prioritizing personal time Preserving friendships, hobbies Leave work at work Other program activities: Full Program: Equipped and Empowered: Thriving as Women in GI https://bit.ly/3Zmqy1I] Podcast 1: Finding Your Friendtors: Mentors, Sponsors, and Allies https://bit.ly/3LuKzO6 Podcast 2: Embracing Your Value: Tools and Strategies for Optimizing Professional Growth and Development https://bit.ly/3RsFl9i ClinicalThought: Expert Commentary on Thriving as Women in GI https://bit.ly/48oi5iS Link to CME: Claim Credit: https://bit.ly/48oi5iS [After selecting the “Continue to Post Test” button:] To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select 1 best answer for each question. When you have completed all the questions, press the "Continue" button at the bottom. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
	Addressing Health Disparities in Anemia of Chronic Kidney Disease	07 Dec 2022	00:22:54
This podcast episode is part of a multimedia program discussing the impact of health disparities in anemia of chronic kidney disease (CKD) on patient outcomes. Tune in to hear Santosh Saraf, MD, and Milda Saunders, MD, MPH, highlight mitigation strategies to improve screening and management. The overview will include: The definition of CKD and the relative prevalence in specific minority groups How health disparities affect CKD-related clinical and patient outcomes Appropriate screening techniques to diagnose patients with anemia of CKD Strategies to address health disparities to improve patient outcomes in the management of anemia of CKD Presenters: Santosh Saraf, MD Associate Professor of Medicine Division of Hematology and Oncology Department of Medicine University of Illinois at Chicago Chicago, Illinois Milda Saunders, MD, MPH Associate Professor of Medicine Department of Medicine University of Chicago Chicago, Illinois To view other program offerings, including a CE-certified on-demand webcast, a ClinicalThought commentary, and to download slides, visit: https://bit.ly/3iL07S0 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

About Methodology Contact Support me Privacy Policy Legal Notice